⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3885055 | 0.87 | — | — | |
| SCHEMBL8311400 | 0.87 | — | — | |
| SCHEMBL26073542 | 0.76 | MAOA (0.39) | — | |
| SCHEMBL27760622 | 0.66 | — | — | |
| SCHEMBL31412624 | 0.66 | — | — | |
| SCHEMBL226972 | 0.66 | — | — | |
| SCHEMBL3656580 | 0.65 | — | — | |
| SCHEMBL28561922 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL3407509 | 0.65 | — | — | |
| SCHEMBL18663188 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1450784-A4 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | CONFORMA THERAPEUTICS CORP (US) | 2005-02-09 | — | — | EP | disclosed |
| EP-1450784-A2 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | Conforma Therapeutics Corporation (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003041643-A2 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | CONFORMA THERAPEUTICS CORPORATION (US) | 2003-05-22 | — | — | WO | disclosed |